Chemoinformaics analysis of Cyanidin 3, 7, 3-triglucoside
| Molecular Weight | 773.67 | nRot | 10 |
| Heavy Atom Molecular Weight | 732.342 | nRig | 35 |
| Exact Molecular Weight | 773.214 | nRing | 6 |
| Solubility: LogS | -1.473 | nHRing | 4 |
| Solubility: LogP | -2.292 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 95 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 54 | No. of Aromatic Carbocycles | 2 |
| nHetero | 21 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 41 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 21 | No. of Arom Bond | 17 |
| nHA | 20 | APOL | 99.2905 |
| nHD | 14 | BPOL | 53.2835 |
| QED | 0.086 |
| Synth | 5.488 |
| Natural Product Likeliness | 1.293 |
| NR-PPAR-gamma | 0.418 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.989 |
| HIA | 0.994 |
| CACO-2 | -6.537 |
| MDCK | 0.000311384 |
| BBB | 0.509 |
| PPB | 0.478827 |
| VDSS | 0.435 |
| FU | 0.296923 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.004 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.078 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.121 |
| CYP3a4-inh | 0.001 |
| CYP3a4-sub | 0 |
| CL | 1.26 |
| T12 | 0.364 |
| hERG | 0.01 |
| Ames | 0.137 |
| ROA | 0.046 |
| SkinSen | 0.003 |
| Carcinogencity | 0.1 |
| EI | 0.003 |
| Respiratory | 0.002 |
| NR-Aromatase | 0.812 |
| Antiviral | Yes |
| Prediction | 0.792744 |